Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LPA”

145 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 145 results

Not applicableLooking for participantsNCT02740634
What this trial is testing

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

Who this might be right for
Atypical Alzheimer's DiseaseLogopenic Progressive Aphasia (LPA)Posterior Cortical Atrophy (PCA)+5 more
Mayo Clinic 60
Not applicableLooking for participantsNCT07508007
What this trial is testing

Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings

Who this might be right for
Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice
Novartis Pharmaceuticals 4,500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07767513
What this trial is testing

Study of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of Cardiovascular Events

Who this might be right for
Lipoprotein Disorder
Shandong Suncadia Medicine Co., Ltd. 60
Post-approval studies (Phase 4)UnknownNCT00433823
What this trial is testing

A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis

Who this might be right for
Coronary Heart DiseaseDiabetes MellitusNon-Coronary Atherosclerotic Disease+1 more
Abant Izzet Baysal University
Testing effectiveness (Phase 2)Active Not RecruitingNCT07185776
What this trial is testing

HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Who this might be right for
Lipoprotein Disorder
Fujian Shengdi Pharmaceutical Co., Ltd. 203
Not applicableActive Not RecruitingNCT06157983
What this trial is testing

Evaluation of Cascade Screening for Elevated Lipoprotein(a)

Who this might be right for
Cardiovascular DiseasesDyslipidemiasHereditary Diseases
Karolinska Institutet 1,950
Early research (Phase 1)Study completedNCT02414594
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS APO(a)-LRx in Healthy Volunteers With Elevated Lipoprotein(a)

Who this might be right for
Elevated Lipoprotein(a)
Ionis Pharmaceuticals, Inc. 60
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Early research (Phase 1)Study completedNCT03626662
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a)

Who this might be right for
Cardiovascular Disease
Amgen 79
Not applicableNot Yet RecruitingNCT07382414
What this trial is testing

Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial

Who this might be right for
Ischemic Heart DiseaseCoronary Artery DiseaseHypercholesterolemia+2 more
Tor Biering-Sørensen 123,000
Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Not applicableNot Yet RecruitingNCT07197242
What this trial is testing

Prognostic Role of Lipoprotein(a) in Elective Percutaneous Coronary Revascularization

Who this might be right for
PCI
Assiut University 156
Not applicableActive Not RecruitingNCT07533656
What this trial is testing

VAP-Measured Lipid Subfractions and In-Stent Restenosis After PCI

Who this might be right for
In-Stent RestenosisCoronary Artery Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine 3,600
Testing effectiveness (Phase 2)Looking for participantsNCT07327840
What this trial is testing

Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

Who this might be right for
Lipoprotein Disorder
Kylonova (Xiamen) Biopharma co., LTD. 204
Testing effectiveness (Phase 2)Looking for participantsNCT07614984
What this trial is testing

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

Who this might be right for
Lipoprotein(a)
Merck Sharp & Dohme LLC 750
Not applicableStudy completedNCT01095744
What this trial is testing

Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease

Who this might be right for
Alzheimer's DiseasePosterior Cortical AtrophyLogopenic Progressive Aphasia
Institut National de la Santé Et de la Recherche Médicale, France 60
Large-scale testing (Phase 3)Looking for participantsNCT06813911
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals 340
Testing effectiveness (Phase 2)Looking for participantsNCT06496243
What this trial is testing

Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels

Who this might be right for
Dyslipidemias
NewAmsterdam Pharma 69
Not applicableStudy completedNCT05378529
What this trial is testing

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Who this might be right for
Atherosclerotic Cardiovascular Disease
Amgen 39,480
Testing effectiveness (Phase 2)Study completedNCT01488097
What this trial is testing

Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency

Who this might be right for
Cholesterol Ester Storage Disease (CESD)Lysosomal Acid Lipase DeficiencyLAL-Deficiency
Alexion Pharmaceuticals, Inc. 8
Next Page